Browsing by Author "Koral, Lokman"
Now showing items 1-5 of 5
-
Classic Kaposi's sarcoma: A review of 156 cases
Çetin, Bülent; Aktaş, Bilge; Bal, Oznur; Algin, Efnan; Akman, Tülay; Koral, Lokman; Kaplan, Mehmet Ali; Uncu, Doğan; Özet, Ahmet (Elsevier Ltd, 2018)Background: Kaposi's sarcoma (KS) is a reactive, multifocal, multicentric, angiogenic neoplastic proliferation that is thought to originate from endothelial cells that are infected with human herpesvirus-8 (HHV-8). This ... -
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study
Akdeniz, Nadiye; Kaplan, Muhammet Ali; Uncu, Doğan; İnanç, Mevlüde; Kaya, Serap; Dane, Faysal; Küçüköner, Mehmet; Demirci, Ayşe; Bilici, Mehmet; Durnalı, Ayse Gök; Koral, Lokman; Şendur, Mehmet Ali Nahit; Erol, Cihan; Türkmen, Esma; Ölmez, Ömer Fatih; Açıkgöz, Özgür; Laçin, Şahin; Şahinli, Hayriye; Urakçı, Zuhat; Işıkdoğan, Abdurrahman (Springer, 2021)Purpose We aim to compare the efficiency and toxicity of three different 5-fluorouracil (5-FU) administration types in 5-FU, leucovorin, and oxaliplatin (FOLFOX) combination treatment for adjuvant therapy in colorectal ... -
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
Yasin, Ayşe İrem; Aydın, Sabin Göktaş; Sümbül, Bilge; Koral, Lokman; Şimşek, Melih; Geredeli, Çağlayan; Kalkan, Ziya (Future Medicine LTD., 2022)Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against ... -
Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience
Cetin, Bulent; Benekli, Mustafa; Oksuzoglu, Berna; Koral, Lokman; Ulas, Arife; Dane, Faysal; Turker, Ibrahim (Karger, 2012)Background: We investigated the clinical outcome of patients with brain metastases (BMs) from human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) treated with lapatinib and capecitabine ... -
Lapatinib plus capecitabine for HER2-positive advanced breast cancer: a multicentre study of Anatolian Society of Medical Oncology (ASMO)
Cetin, Bulent; Benekli, Mustafa; Turker, Ibrahim; Koral, Lokman; Ulas, Arife; Dane, Faysal; Oksuzoglu, Berna (Taylor & Francis Ltd, 2014)Lapatinib is the first dual tyrosine kinase inhibitor of human epidermal growth factor receptor type 2 (HER2/neu) and epidermal growth factor receptor (EGFR). The present study evaluated the efficacy and tolerability of ...
